ГЕНЕТИКА АУТИЗМА (ОБЗОР ЗАРУБЕЖНОЙ ЛИТЕРАТУРЫ)
https://doi.org/10.17650/2073-8803-2013-8-3-31-45
Аннотация
Аутизм может встречаться при хромосомных и генетических синдромах, пороках развития головного мозга, болезнях обмена и др. В связи с этим в настоящее время принят термин «атипичный» или «синдромальный» аутизм – аутизм, являющийся одним из симптомов другого заболевания. Генетические и хромосомные причины составляют 25-50% случаев аутизма. Авторы представили подробный обзор литературы, посвященный генетическим аспектам аутизма. В статье рассматриваются известные наследственные заболевания, проявляющиеся аутизмом, классификации генов-кандидатов аутизма, теории патогенеза аутизма, подходы к диагностике, а также проблемы, связанные с генетическим консультированием при диагностике аутизма.
Об авторах
М. Ю. БобыловаРоссия
Н. Л. Печатникова
Россия
Список литературы
1. Alarcon M., Cantor R.M., Liu C. et al. The Autism Genetic Resource Exchange Consortium & Geschwind, D.H. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families // American Journal of Human Genetics. – 2002. – V. 70. – P. 60-71.
2. Alarcon M., Abrahams B., Stone S. et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene // Am J Hum Genet. – 2008. – V. 82(1). – P. 150-159.
3. Antshel M., Aneja A., Strunge L. et al. Autistic spectrum disorders in velo-cardio facial syndrome (22q11.2 deletion) // Journal of Autism and Developmental Disorders. – 2007. – V. 37. – P. 1776-1786.
4. Asato M.R., Hardan A.Y. Neuropsychiatric problems in tuberous sclerosis complex // Journal of Child Neurology. – 2004. – V. 19. – P. 241-249.
5. Bailey A., Le Couteur A., Gottesman I. et al. Autism as a strongly genetic disorder: evidence from a British twin study // Psychol Med. – 1995. V. 25(1). – P. 63-77.
6. Bailey A., Luthert P., Dean A. et al. A clinicopathological study of autism // Brain. – 1998. – V. 121 (5). – P. 889-905.
7. Bassell G.J. and Warren S.T. Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function // Neuron. – 2008. – V. 60. – P. 201-214.
8. Baron-Cohen S., Scott F.J., Allison C. Prevalence of Autism-Spectrum Conditions: UK School-Based Population Study // Br J Psychiatry. – 2009. – V. 194. – P. 500-509.
9. Bauman, M. Kemper T. L. Histoanatomic observations of the brain in early infantile autism // Neurology. – 1985. – V. 35(6). – P. 866-74.
10. Beard E. & Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions // Journal of Neurochemistry. – 2010. – V. 115. – P. 297-313.
11. Bedogni F., Hodge R.D., Nelson B.R. Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein expressed in developing brain regions implicated in autism neuropathology // Gene Expr Patterns. – 2010. – V. 10. – P. 9-15.
12. Ben Zeev B., Bebbington A., Ho G. et al. The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome // American Academy of Neurology. – 2009. – V. 72. – P. 1242-1247.
13. Bhalla K., Luo Y., Buchan T. et al. Alterations in CDH15 and KIRREL3 in Patients with Mild to Severe Intellectual Disability // Am J Hum Genet. – 2008. – V. 83. – P. 703-713.
14. Boddaert N., Zilbovicius M., Philipe A., et al. MRI findings in 77 children with non-syndromic autistic disorder // PLoS One. – 2009. – V. 4. – e4415.
15. Bolte S., Dziobek I., & Poustka F. Brief report: The level and nature of autistic intelligence revisited // J Autism Dev Disord. – 2009. – V. 39(4). – P. 678-682.
16. Bourgeois J.A., Coffey S.M., Rivera S.M. et al. A review of fragile X premutation disorders: expanding the psychiatric perspective // Journal of Clinical Psychiatry. – 2009. – 70. – P. 852-862.
17. Bourgeron T. A synaptic trek to autism // Curr Opin Neurobiol. – 2009. – V. 19. – P. 231-234.
18. Bremer A. Copy number variation characteristics in subpopulations of patients with autism spectrum disorders // American Journal of Human Genetics Part B Neuropsychiatric Genetics. – 2011. – V. 156 (2). – P. 115-124.
19. Brkanac Z., Raskind W.H., Kin B.H. Pharmacology and genetics of autism: implications for diagnosis and treatment // NIH Public Access. – 2008. – V. 5. – P. 599-607.
20. Cantor R.M., Yoon J.L., Furr J., Lajonchere C.M. Paternal age and autism are associated in a family-based sample // Mol Psychiatry. – 2007. – V. 12(5). – P. 419-21.
21. Carney R.M., Wolpert C.M., Ravan S.A et al. Identification of MeCP2 mutations in a series of females with autistic disorder // Pediatr Neurol. – 2003. – V. 28(3). – P. 205-211.
22. Chelly J., Khelfaoui M., Francis F. et al. Genetics and Pathophysiology of Mental Retardation // Eur J Hum Genet. – 2006. – V. 14. – V. 701-713.
23. Cheng Y., Sudarov A., Szulc et al. The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum // Development. – 2010. – V. 137(3). – P. 519-529.
24. Clarke D.F., Roberts W., Daraksan M. The Prevalence of Autistic Spectrum Disorder in Children Surveyed in a Tertiary Care Epilepsy Clinic // Epilepsia. – 2005. – V. 46. – P. 1970-1977.
25. Croen L.A., Najjar D.V., Fireman B., Grether J.K. Maternal and paternal age and risk of autism spectrum disorders // Arch Pediatr Adolesc Med. – 2007. – V. 161(4). – P. 334-40.
26. Danielsson S., Gillberg I.C., Billstedt E. et al. Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood // Epilepsia. – 2005. – V. 46(6). – P. 918-923.
27. Durand C.M., Betancur C., Boeckers T.M., Bockmann J. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders // Nat Genet. – 2007. – V. 39(1). – P. 25-27.
28. Eagleson K.L., Campbell D.B., Thompson B.L. et al. The autism risk genes MET and PLAUR differentially impact cortical development // Autism Res. – 2011. – V. 4(1). – P. 68-83.
29. El-Fishawy P., State M.W. The genetics of autism: key issues, recent findings and clinical implications // The Psychiatric Clinics of North America. – 2010. – V. 33. – P. 83-105.
30. Falk R.E., Casas K.A. Chromosome 2q37 deletion: clinical and molecular aspects // American Journal of Medical Genetics. – 2007. – V. 145. – P. 357-371.
31. Fatemi S.H., Reutiman T.J., Folsom T.D. MRNA and Protein Levels for GABA Aalpha4, alpha5, beta1 and GABABR1 Receptors are Altered in Brains from Subjects with Autism // J Autism Dev Disord. – 2010. – V. 40. –P. 743-750.
32. Fedulov V., Rex C.S., Simmons D.A. et al. Evidence that Long-Term Potentiation Occurs within Individual Hippocampal Synapses during Learning // J Neurosci. – 2007. – V. 27. – P. 8031-8039.
33. Fernandez B.A., Roberts W., Chung B. et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder // Journal of Medical Genetics. – 2010. – V. 47. – P. 195-203.
34. Franke P., Leboyer M., Gansicke M. et al. Genotype-phenotype relationship in female carriers of the permutation and full mutation of FMR-1 // Psychiatry Research. – 1998. – V. 80. – P. 113-127.
35. Freitag C.M., Staal W., Klauck S.M. et al. Genetics of autistic disorders: review and clinical implications // European Child & Adolescent Psychiatry. – 2010. – V. 19. – P. 169-178.
36. Gardoni F. MAGUK Proteins: New Targets for Pharmacological Intervention in the Glutamatergic Synapse // Eur J Pharmacol. – 2008. – V. 585. – P. 147-152.
37. Gepner B., Feron F. Autism: a world changing too fast for a mis-wired brain? // Neurosci Biobehav Rev. – 2009. –V. 33(8). – P. 1227-1242.
38. Graf E.R., Daniels R.W., Burgess R.W. Rab3 Dynamically Controls Protein Composition at Active Zones // Neuron. – 2009. – V. 64. – P. 663-677.
39. Guilmatre A., Dubourg C., Mosca et al. Recurrent rearrangements in synaptic and neurodevelopment genes and shared biologic pathways in schizophrenia, autism, and mental retardation // Archives of General Psychiatry. – 2009. – V. 66. – P. 947-956.
40. Green, J.J., Hollander E. Autism and ocytocin: new developments in translational approaches to therapeutics // Neurotherapeutics. – 2010. – V. 7. – P. 250-257.
41. Gregory S.G., Connelly J.J., Towers A.J. et al. Genomic and epigenetic evidence for oxytocin receptor deficiency in autism // BMC Med. – 2009. – V. 22. – P. 62.
42. Hagerman R.J. Fragile X syndrome. In S.B. Cassidy & J.E. Allanson (eds.) Management of Genetic Syndromes, 2005. – pp. 251-263.
43. Hamdan F.F., Gauthier J., Araki Y., et al Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability // Am J Hum Genet. – 2011. – V. 88. – P. 306-316.
44. Hayashi M.K., Tang C., Verpelli C., Narayanan R., The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure // Cell. – 2009. – V. 137. – P. 159-171.
45. Hessl D., Rivera S.M., Reiss, A.L. The neuroanatomy and neuroendocrinology of fragile X syndrome // Mental Retardation and Developmental Disabilities Research Reviews. – 2004. – V. 10. – P. 17-24.
46. Hogart A., Wu D., LaSalle J.M., Schanen M.C. The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13 // Neurobiology of Disease. – 2010. – V. 38. – P. 181-191.
47. Hughes J.R., Melyn M. EEG and Seizures in Autistic Children and Adolescents: Further Findings with Therapeutic Implications // Clin EEG Neurosci. – 2005. – V. 36. – P. 15-20.
48. Hutsler, J.J., Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders // Brain Res. – 2009. – V. 1309. – P. 83-94.
49. Hynes K., Tarpey P., Dibbens L.M., et al. Epilepsy and Mental Retardation Limited to Females with PCDH19 Mutations can Present De Novo Or in Single Generation Families // J Med Genet. – 2010. – V. 47(3). – P. 211-6.
50. Insel T.R. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin and affiliative behavior // Neuron. – 2010. – V. 65. – P. 768-779.
51. Kaufman L., Ayub M., Vincent J.B. The Genetic Basis of Non-Syndromic Intellectual Disability: A Review // J Neurodev Disord. – 2010. – V. 2. – P. 182-209.
52. Kim H.G., S. Kishikawa A.W. Higgins et al. Disruption of neurexin 1 associated with autism spectrum disorder // Am J Hum Genet. – 2008. – V. 82(1). – P. 199-207.
53. Kogan M.D., Blumberg S.J., Schieve L.A. Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder among Children in the US, 2007 // Pediatrics. – 2009. – V. 124. – P. 1395-1403.
54. Kumar R.A., Christian S.L. Genetics of autism spectrum disorders // Current Neurology and Neuroscience Reports. – 2009. – V. 9. – P. 188-197.
55. Lee H.J., Macbeth A.H., Pagani J.H. et al. Oxytocin: The great facilitator of life // Progress in Neurobiology. – 2009. – V. 88. – P. 127-151.
56. Lichtenstein P., Carlstrom E., Rastam M. et al. The gentics of autism spectrum disorders and related neuropsy-chiatric disorders in childhood // American Journal of Psychiatry. – 2010. – V. 167. – P. 1357-1363.
57. Lintas C., Persico A.M. Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist // Journal of Medical Genetics. – 2009. – V. 46. – P. 1-8.
58. Malaspina D., Reichenberg A., Weiser M., et al. Paternal age and intelligence: implications for age-related genomic changes in male germ cells // Psychiatr Genet. – 2005. – V. 15(2). – P. 117-125.
59. Manzi B., Loizzo A.L., Giana G., Curatolo, P. Autism and metabolic diseases // Journal of Child Neurology. – 2008. – V. 23. – P. 307-314.
60. Marco E.L., Skuse D.H. Autism-lessons from the X chromosome // Scan. – 2006. – V. 1. – P. 183-193.
61. Matijevic T., Knezevic J., Slavica M., Pavelic J. Rett Syndrome: from the gene to the disease // European Neurology. – 2009. – V. 61. – P. 3-10.
62. Matuszek G., Talebizadeh Z. Autism genetic database (AGD): a comprehensive database including autism susceptibility gene-CNV's integrated with known noncoding RNAs and fragile sites // BMC Medical Genetics. – 2009. – V. 10. – P. 102.
63. McBride K.L., Varga E.A., Pastore M.T., Confirmation Study of PTEN Mutations among Individuals with Autism Or Developmental delays/mental Retardation and Macrocephaly // Autism Res. – 2010. – V. 3. – P. 137-141.
64. Miller D.T. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders // Journal of Medical Genetics. – 2009. – V. 46. – N. 4. – P. 242-248.
65. Miles J.H., Hadden L.L., Takahashi T.N., Hillman R.E. Head Circumference is an Independent Clinical Finding Associated with Autism // Am J Med Genet. – 2000. – V. 95. – P. 339-350.
66. Miles J.H., Hillman R.E. Value of a Clinical Morphology Examination in Autism // Am J Med Genet. – 2000. – V. 91. – P. 245-253.
67. Miles J.H., Takahashi T.N., Bagby S., Essential Versus Complex Autism: Definition of Fundamental Prognostic Subtypes // Am J Med Genet. – 2005. – V. 135. – P. 171-180.
68. Morrow E.M., Yoo S.Y., Flavell S.W. et al. Identifying autism loci and genes by tracing recent shared ancestry // Science. – 2008. – V. 321(5886). – P. 218-223.
69. Moessner R., Marshall C.R., Sutcliffe J.S. et al. Contribution of SHANK3 mutations to autism spectrum disorder // Am J Hum Genet. – 2007. – V. 81(6). – P. 1289-97.
70. Muhle R., Trentacoste S.V., Rapin I. The genetics of autism // Pediatrics. – 2004. – V. 113(5). – P. 472-486.
71. Nasrallah F., Feki M., Kaabachi N. Creatine and creatine deficiency syndromes: biochemical and clinical aspects // Pediatric Neurology. – 2010. – V. 42. – P. 163-171.
72. Niklasson L., Rasmussen P., Oskarsdottir S. Gillberg C. Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome // Research in Developmental Disabilities. – 2009. – V. 30. – P. 763-773.
73. Noor A., Whibley A., Marshall C.R. et al. Disruption at the PTCHD1 Locus on Xp22.11 in Autism Spectrum Disorder and Intellectual Disability // Sci Transl Med. – 2010. – V. 2(49). – P. 49-68.
74. Pavlowsky A., Gianfelice A., Pallotto M., et al A Postsynaptic Signaling Pathway that may Account for the Cognitive Defect due to IL1RAPL1 Mutation // Curr Biol. – 2010. – V. 20. – P. 103-115.
75. Paylor R., Glaser B., Mupo A. et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome // Proceedings of the National Academy of Sciences. – 2006. – V. 103. – P. 7729-7734.
76. Pinto D., Pagnamenta A.T., Klei L., et al Functional Impact of Global Rare Copy Number Variation in Autism Spectrum Disorders // Nature. – 2010. – V. 466(7304). – P. 368-72.
77. Piven J., Arndt S., Bailey J., Andreasen N. Regional brain enlargement in autism: a magnetic resonance imaging study // J Am Acad Child Adolesc Psychiatry. – 1996. – V. 35(4). – P. 530-6.
78. Puleo C.M., Reichenberg A., Smith C.J. et al. Do autism related personality traits explain higher paternal age in autism? // Mol Psychiatry. – 2008. – V. 13(3). – P. 243-4.
79. Rauch A., Hoyer J., Guth S. et al. Diagnostic Yield of various Genetic Approaches in Patients with Unexplained Developmental Delay Or Mental Retardation // Am J Med Genet A. – 2006. – V. 140. – P. 2063-2074.
80. Raymond G.V., Bauman M.L., Kemper T.L. Hippocampus in autism: a Golgi analysis // Acta Neuropathol. – 1996. – V. 91(1). – P. 117-9.
81. Redies C. Cadherins in the central nervous system // Prog Neurobiol. – 2000. – V. 61(6). – P. 611-648.
82. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems // Genes, Brain & Behavior. – 2003. – V. 2(5). – P. 255-267.
83. Rujescu D., Ingason A., Cichon S. et al. Disruption of the neurexin 1 gene is associated with schizophrenia // Hum Mol Genet. – 2009. – V. 18(5). – P. 988-96.
84. Salomons G.S., van Dooren S.J.M., Verhoeven N.M., et al. X-linked creatine transporter defect: an overview // Journal of Inherited Metabolic Disorders. – 2003. – V. 26. – P. 309-318.
85. Sebat J. Strong association of de novo copy number mutations with autism // Science. – 2007. – V. 316(5823). – P. 445-449.
86. Shprintzen R.J. Velo-cardio-facial syndrome: a distinctive behavioural phenotype // Mental Retardation and Developmental Disabilities. – 2000. – V. 6. – P. 142-147.
87. Steiner C.E., Guerreiro M.M., Marques-de-Faria A.P. Brief Report: Acrocallosal Syndrome and Autism // J Autism Dev Disord. – 2004. – V. 34. – P. 723-726.
88. Spence S.J., Schneider M.T. The Role of Epilepsy and Epileptiform EEGs in Autism Spectrum Disorders // Pediatr Res. – 2009. – V. 65. – P. 599-606.
89. Stromme P., Mangelsdorf M.E., Scheffer I.E., Gecz J. Infantile Spasms, Dystonia, and other X-Linked Phenotypes Caused by Mutations in Aristaless Related Homeobox Gene, ARX // Brain Dev. – 2002. – V. 24. – P. 266-268.
90. Tuchman R. and Rapin I. Epilepsy in Autism // Lancet Neurol. – 2002. – V. 1. – P. 352-358.
91. Verhoeven W.M.A., Tuinier S., van der Burgt I. Top-down or bottom-up: contrasting perspectives on psychiatric diagnoses // Biologics: Targets & Therapy. – 2008. – V. 2. – P. 409-417.
92. Verhoeven W.M.A., Csepan R., Marcelis C. et al. Sanfilippo B in an elderly female psychiatric patient: a rare but relevant diagnosis in presenile dementia // Acta Psychiatrica Scandinavica. – 2010. – V. 122. – P. 162-165.
93. Vernes S.C., Newbury D.F., Abrahams B.S. et al. A functional genetic link between distinct developmental language disorders // N Engl J Med. – 2008. – V. 359(22). – P. 2337-2345.
94. Vogels A., Verhoeven W.M.A., Tuinier S. et al. The psychopathological phenotype of velo-cardio-facial syndrome // Annales de Genetique. – 2002. – V. 45. – P. 89-95.
95. Volkmar F.R., Szatmari P., Sparrow S.S. Sex Differences in Pervasive Developmental Disorders // J Autism Dev Disord. – 1993. – V. 23. – P. 579-591.
96. Vorstman J.A.S., Morcus M.E.J., Duijff S.N et al. The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms // Journal of American Academy of Child and Adolescent Psychiatry. – 2006. – V. 45. – P. 1104-1113.
97. Wang K., Zhang H., Ma D. et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders // Nature. – 2009. – V. 459(7246). – P. 528-533.
98. Weiss L.A., Arking D.E., The Gene discovery Project of Johns Hopkins & The Autism Consortium. A genome-wide linkage and association scan reveals novel loci for autism // Nature. – 2009. – V. 461. – P. 802-808.
99. Weissman J.R., Kelley R.I., Bauman M.L. et al. Mitochoncrial disease in autism spectrum disorder patients: a cohort analysis // Plos One. – 2008. – V 3. – e3815.
100. Wiznitzer M. Autism and tuberous sclerosis // Journal of Child Neurology. – 2004. – V. 19. – P. 675-679.
101. Zecavati N., Spence S.J. Neurometabolic disorders and dysfunction in autism spectrum disorders // Current Neurology and Neuroscience Reports. – 2009. – V. 9. – P. 129-136.
102. Zoghbi H.Y., Warren S.T. Neurogenetics: advancing the "next-generation" of brain research // Neuron. – 2010. – V. 68(2). – P. 165-73.
Рецензия
Для цитирования:
Бобылова М.Ю., Печатникова Н.Л. ГЕНЕТИКА АУТИЗМА (ОБЗОР ЗАРУБЕЖНОЙ ЛИТЕРАТУРЫ). Русский журнал детской неврологии. 2013;8(3):31-45. https://doi.org/10.17650/2073-8803-2013-8-3-31-45
For citation:
Bobylova M.Yu., Petchatnikova H.L. GENETICS OF AUTISTIC DISORDER (REVIEW OF FOREIGN LITERATURE). Russian Journal of Child Neurology. 2013;8(3):31-45. (In Russ.) https://doi.org/10.17650/2073-8803-2013-8-3-31-45